Exploratory, Phase 0 Study of Positron Emission Tomography (PET) Imaging Agent, F-18 RGD-K5
Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to get information from volunteers without cancer and
patients with cancer who have received a new investigational study agent called, "[F-18]
RGDK5," to evaluate biodistribution and dosimetry for the study agent and determine F-18
RGD-K5 uptake in angiogenic tumor. the system.